SCHEMBL30762873

SCHEMBL30762873

Cc1ccccc1-c1cc(=O)oc2cc(OC(C)C(=O)N3CC[C@H](C(=O)O)C3)ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ ALDH1A1 P00352 5/20 0.54
▸ HPGD P15428 4/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ RAB9A P51151 1/20 0.53
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ AR P10275 1/20 0.48
▸ RCE1 Q9Y256 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ MAPT P10636 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ ALDH2 P05091 1/20 0.43
▸ IGLV6-57 P01721 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20840631 1.00 CYP3A4 (0.61) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839347 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839096 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL30056586 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL30058118 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839095 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839458 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL30056525 0.95 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839587 0.93 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL20839588 0.93 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback